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Modulating Factors in the Expression of
Radiation-Induced Oncogenic
Transformation
by Eric J. Hall* and Tom K. Hei*
Many assays foroncogenic transformation have been developed rangingfrom those in established rodent
cell lines where morphological alteration is scored, to those in human cells growing in nude mice where
tumor invasiveness is scored. In general, systems that are most quantitative are also the least relevant in
terms of human carcinogenesis and human risk estimation. The development of cell culture systems has
made it possible to assess at the cellular level the oncogenic potential of a variety of chemical, physical
and viral agents. Cell culture systems afford the opportunity to identify factors and conditions that may
prevent or enhance cellular transformation by radiation and chemicals. Permissive and protective factors
in radiation-induced transformation include thyroid hormone and the tumor promoter TPA that increase
the transformation incidence for a given dose of radiation, and retinoids, selenium, vitamin E, and 5-
aminobenzamide that inhibit the expression of transformation. Densely ionizing a-particles, similar to
those emitted by radon daughters, are highly effective in inducing transformations and appear to interact
in a supra-additive fashion with asbestos fibers. The activation of a known dominant oncogene has not
yet been demonstrated in radiation-induced oncogenic transformation. The most likely mechanism for
radiation activationofanoncogenewouldbeviatheproduction ofachromosomaltranslocation. Radiation
also efficiently induces deletions and may thus lead to the loss of a suppressor gene.
Introduction
Following the report by Berwald and Sachs on the
induction of morphological transformants in Syrian
hamster embryo cells by the chemical carcinogen
benzo(a)pyrene more than two decades ago (1), a host
ofin vitro oncogenic transformation systems have been
developed based on a variety ofrodent and human cells
(2-5). These in vitro model systems represent a pow-
erful research tool in addressing two diverse aspects of
cancer research. First, they may be used to accumulate
data that are essentially pragmatic in nature. These in
vitro systems, free of host-mediated homeostatic influ-
ences, afford the opportunity to evaluate both qualita-
tive and quantitative aspects of oncogenic transforma-
tion. For example, they are useful to compare and
contrast the oncogenic potential of a variety ofchemical
and physical agents. As such, they occupy a useful in-
termediate position between the bacterial mutagenesis
assays, which are quick and inexpensive, and animal
studies, which are cumbersome and inordinately ex-
pensive.
Second, in vitro systems make it possible to study
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the cellular and molecular mechanisms involved in ra-
diation or chemically induced carcinogenesis, inasmuch
as they represent models for in vitro tumorigenesis in
whichthevariousstepscanbemanipulatedandmodified
more easily and in a more controlled way. In vitro sys-
tems afford the opportunity to study dose-related and
time-dependent interactions of radiation with single
cells and identify factors and conditions that may pre-
ventorenhance cellulartransformationbyradiationand
chemicals.
Therecentadvancesinmolecularbiologyusingcloned
fragments of viral transforming genes and the subse-
quentdiscovery ofsuchproto-oncogenes inmanyanimal
and human tumors using the transfection technique
have highlighted the practical need forthese model sys-
tems.
Criteria of Malignancy
A number of different end points can be scored in
transformation assays. The possible end points in order
ofincreasing relevance for carcinogenesis in the human
are as follows: altered morphology; growth in soft agar;
unlimited growth; transplantability in animals; inva-
siveness; and metastasis.
By scoring the altered morphology of a colony or fo-
cus, it is quite practical to identify one transformed cell
in a population of 106 cells in an experiment ofmanage-HALL AND HEI
able size. Assays that depend on this criteria, such as
thosewithSyrianHamsterembryocells(1,2),C3H10T1/2
(3) or 3T3 (4) cells, can therefore be used in highly
quantitative experiments with radiation to determine,
for example, the effects ofradiation quality orradiation
dose rate on the influence ofprotective and permissive
factors. Unfortunately, the altered morphology ofa col-
ony orfocus in a Petri dish is farremoved from an overt
tumor in the human, and the limitations ofthe systems
mustbeappreciated. Atthe otherextreme, forsystems
that score invasiveness and/or metastatic potential
(6,7), the assay of treated cells must be performed in
animals with a consequent loss ofresolution and quan-
tification. For example, it would be out ofthe question
to obtain detailed dose-response relationships for two
types of radiation to allow an assessment of relative
biological effectiveness when scoring tumor invasive-
ness as an end point.
Assay Systems for Oncogenic
Transformation
The following list of available assay systems is rep-
resentative butbynomeans exhaustive. a) Syrian ham-
ster embryo (SHE), C3H 10T1/2, and NIH 3T3 cell sys-
tems are the most quantitative, though by the same
token the most removed from relevance to cancer risk
assessment in the human. b) The HeLa-normal human
fibroblast hybrid-cell line may be as quantitative as
those in group a and it has the advantage that these
are human cells. c) The RTE (respiratory tract epithe-
lium) systemintheratlendsitselftomechanisticstudies
and is also a quantitative assay system for carcinogenic
agents including radiation, though it is not as quanti-
tative orreproducible as the systems ofgroup a. d) The
thyroid and mammary cell systems in the rat, which
are assayed for both cell survival and oncogenicity by
transplantation into a fat pad of the animal, represent
attractive model systems for the study of oncogenic
transformation that is quantitative and amenable to a
number ofstudies. e) Mouse skeletoblasts may be stud-
ied in a semi-quantitative way afterbeinginfected with
retroviruses, but quantitative studies comparable to
those reported for groups a and b have not been re-
ported. J) Human fibroblasts have been studied exten-
sively, but they must be immortalized in one of three
ways: infection with the SV40 virus, irradiation with
multiple doses ofgamma rays to a total dose of3 Gy or
more, ortransfectionwiththemyconcogene. Following
immortalization by one of these procedures, human fi-
broblasts represent a system potentially suitable for
quantitative studies. g) Human keratinocytes, immor-
talized by a combination ofviruses, have been used for
a variety of studies. The disadvantage is that the kar-
yotype ofthe cell has been drastically altered, as is also
true for C3H 10T1/2, 3T3, and all virally transformed or
oncogene transfected fibroblast lines. h) Human uroe-
pithelial cells have been immortalized by the chemical
carcinogen 3-methylcholanthrene (MCA) and their
propertiescharacterizedextensively, butuptothepres-
ent time they have not been used for studies involving
ionizing radiation. i) Human epithelial cells have been
immortalized with the retrovirus HPV and insertion of
the ras oncogene and may then be used both as a quan-
titative assay system and for mechanistic studies. j)
Human keratinocytes spontaneously immortalized, or
immortalized with the ras oncogene, may subsequently
be grown on a collagen base in the animal. This system
andthe assaysystemdescribedinienjoythe advantage
that the invasive capabilities ofthe induced tumor may
be studied. Up to the present time, these systems have
not been used for quantitative radiation studies.
In the list above, 10 assays of oncogenic transfor-
mation have been arranged in increasing order ofcom-
plexity and possiblerelevance tothe assessment ofcan-
cer risk estimates in the human. The simplest systems
areshort-termexplantsofSHE cellsandtheestablished
cell lines designated, C3H 10T1/2 and Balb/c 3T3, which
are highly quantitative and reproducible involving fi-
broblasts rather than epithelial cells, and are far re-
moved from the real life situation of carcinogenesis in
the human. On the other hand, increasing relevance in
this list is matched by a decreasing level of quantifica-
tion. While assays involving the established cell lines
are highlyrepeatable and quantitative, systems involv-
ing the human epithelial cells that allow an observation
oftumor invasion, for example, are difficult to use in a
quantitative fashion. All ofthe quantitative studies de-
scribed in the remainder of this paper involve short-
term explants of SHE cells or the established cell line
C3H 10T½/2.
Modulation of Radiation-induced
Transformation
A variety ofagents have beenidentified that can dra-
matically influence the oncogenic transformation poten-
tial of a given dose of radiation. Some ofthese agents
need not be present during irradiation, but may be
added some time later. Results of a series of experi-
ments along these lines are summarized in Figures 1
and 2.
Itisinterestingtonotethatmanipulationofhormonal
levels can dramatically alter the transformation inci-
dence (Fig. 2), demonstrating in the Petri dish what is
evident from experiments with both humans and ani-
mals (8,9). Under hypothyroid conditions, neither X-
raynorbenzo(a)pyrene-inducedtransformationsareex-
pressed (10,11). When thyroid hormone (triiodothyron-
ine) is added to the medium, oncogenic transformation
is expressed in a dose-dependent fashion. The induction
of cellular transforrnation protein by thyroid hormone
and its effect on the oxidative state of cells is thought
to influence the transformation induction in cells (11).
Inthe context ofchemoprevention, i.e., givingacom-
pound to a group of people at high risk of developing
cancer, such aspatients cured oftheirfirstmalignancies
by a combination of radiation and chemotherapy, reti-
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FIGURE 1. Effects ofthyroid hormone status on radiation and chem-
ically induced transformation frequencies in C3H 1OT1/2 cells.
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FIGURE 2. Transformation incidence in C3H 10TI/2 cells by 4 Gy of
y-rays and its modulation byvarious chemical and dietary factors.
noids would appear to be particularly promising and
appropriate. The term retinoid has been used for a
group ofcompounds that include vitamin A and its nat-
uralandsyntheticanalogues. Retinoidshavebeenfound
frequently to block the phenotypic expression oftumor
cells in vitro (12); they also inhibit growth and induce
differentiationinmanyanimalandhumanmalignantcell
types (12). Proposed mechanisms of retinoid action in-
volvetheprotein kinase-C cascade system. Thissystem
may mediate the many diverse actions of retinoids in-
cluding their effects on enzyme synthesis, membrane
properties, growvth factors, binding proteins,,genomic
and postgenomic expression, the extracellular matrix,
and immunologic response. Figure 1 illustrates the
suppression of radiation-induced transformation by vi-
tamin A analogues, first shown more than 10 years ago
(13). A large body ofdata has accumulated with regard
to the importance of retinoids for chemoprevention of
cancer, whetherit be caused by radiation, chemical car-
cinogens, or viral transforming factors (12,14). Exper-
imental studies have shown that chemoprevention with
retinoids inhibits the development of neoplastic or
transformed cell populations invitro as well as in tumor
models such as skin, bladder, and mammary glands in
mice and rats (15). Some of the retinoids have been
foundtobeeffectiveininhibitingtherecurrenceofthese
tumors. More work is needed to determine whether
retinoids inhibit the transformation process per se or
whether they simply inhibit the clonal expansion of in-
itiated cells.
The modulation of transformation by other com-
pounds is also illustrated in Figure 2. Selenium is a
microcomponent of the diet and a cofactor for the en-
zyme glutathione peroxidase, illustratingagainthe sub-
stantial impact that dietary factors may have in cancer
incidence resulting from physical or chemical insults.
Vitamin E is principally an antioxidant, while 3-amino-
benzamide is aninhibitorforthe synthesisofpoly-ADP-
ribose and prevents DNArepairbyinterferingwiththe
ligation process.
Recent data point increasingly to free radicals that
cause avariety ofcascading events associated with lipid
peroxidation and play an important role in carcinogen-
esis, particularly the promotion phase. Superoxide dis-
mutase, a free radical scavenger, inhibits transforma-
tion induced by either radiation or bleomycin if it is in
contact with cells for a prolonged period of time after
treatment with the oncogenic agent.
Hyperthermiais aboutthe onlycancertherapyagent,
apart from the surgeon's knife, that has not been im-
plicated in the induction of cancer as well as its cure.
Hyperthermia has been shown to reduce the incidence
of transformed foci induced by X-rays (16) and also by
a number of chemotherapy agents (17,18).
Transformation by Simulated Radon
Daughter Alphas and the Interaction
with Asbestos
Recent evidence suggests that about halfofthe total
radiation exposure received by the public results from
a-particles emitted by radon daughter products depos-
itedinthelungs. Denselyionizingchargedparticlesthat
simulate the emission from radon can be accelerated in
avandeGraaffmachineandusedtoirradiateC3H 10T1/2
cells in culture. Figure 3 shows survival and transfor-
mation data for cells treated with -y-rays or high LET
helium-3 ions with an LET of 120 keV/,um. The cell
survival curve for -y-rays has a broad initial shoulder,
while that for helium-3 ions is an exponential function
ofdose. Forboth types ofradiation, the transformation
incidence increases with dose, tending towards a pla-
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FIGURE 3. Dose-response relationships for cell survival and onco-
genic transformation in C3H 1T½v cells exposed to graded doses
of y-rays or helium-3 ions with an LET of 120 keV/,um.
teau at a dose of a few GY for y-rays and at about 0.5
Gy for helium-3 ions.
It could be argued that the most relevant parameter
for extrapolation to carcinogenesis in the whole organ-
ism, or whole organ, is transformation per initial cell at
risk, as this ratio represents a balance between trans-
formation and cell killing. This quantity rises at low
doses, reaches a maximum, and subsequently falls at
higher doses as cell killing becomes dominant. For
densely ionizing particles, the peak occurs at a much
lower dose, and reaches a value five times higher than
is the case for y-rays. These high LET particles, which
closely mimic the emission from radon daughters, are
much more effective than y-rays at cell killing, but even
more effective at inducing transformation. The inter-
esting point is that a dose of about 0.5 Gy of helium-3
ions produces an incidence of transformants per initial
cell at risk that is not achieved by any dose of y-rays.
Experiments have also been performed to investigate
an interaction between densely ionizing particles and
asbestosfibers (19). Figure 4shows transformation data
for C3H 10T1/2 cells resultingfrom a24-hr pretreatment
with 5 ,ug/mL crocidolite fibers, or a dose of 0.66 Gy
helium-3 ions, or a combination ofboth. As shown pre-
viously, crocidolite fibers, at concentrations that re-
sulted in only moderate cell killing, induced transfor-
mation frequencies indistinguishable from the
spontaneous rate. However, cells pretreated with cro-
cidolite fibers for24 hrand subsequentlyirradiated with
c-particles exhibited a significantly higher transfor-
mation incidence than after radiation alone. The insert
in thiasfigure s the way in which cells become im-
paled on fibers of certain lengths. The combination of
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FIGURE 4. Transformation incidence inC3H 10T/2cellsforasbestos
fibers and helium-3 ions, delivered alone orin combination. Trans-
formation appears to be supra-additive when asbestos and high-
LET particles are delivered together. (Insert) Cells become im-
paled on fibers ofthe appropriate length.
asbestos fibers and high-LET particles produces a
transformation incidence higher than the simple sum of
the two agents alone. This apparent supra-additivity
has implications for the possible interaction of radon
and asbestos in the environment, and possibly for com-
binations of other environmental pollutants too.
Identification of Oncogenes
Transformation assays play an essential role in iden-
tifying and characterizing oncogenes. The overall strat-
egy is illustrated in Figure 5. Genomic DNA from cell
clones transformed by an agent such as radiation can
be transfected into recipient cells, the cultures can be
expanded in culture, and implanted into animals to de-
termine their tumorigenicity. DNA isolated from the
tumorsformed iscomparedwithknownDNAsequences
to identify the existence of oncogenes by chromato-
graphic techniques.
In the case ofradiation transformation, the exact na-
ture of the oncogenes involved has not yet been eluci-
dated. However, a number ofinteresting experiments
have been performed in this area in which DNA from
atransformed focus, induced byradiation, canbetrans-
fected into recipient cells that subsequently show the
characteristics of malignancy themselves-the ability
to grow in soft agar and eventually produce tumors in
animals (20). Furthermore, Southern blot analysis of
NIH 3T3 and Rat II transfectants carrying oncogenes
from radiation-transfonned C3H 10T/2 on hamster em-
bryo cells indicates that the oncogene(s) responsible for
thetransformationof3T3cellsareunique non-rastrans-
forming genes (20). Recent studies by Sawey and Ken-
nedyusing aradiation-inducedtransformant as asource
oftransforming DNA have demonstrated no activation
ofras oncogene in the resultant tumorigenic recipients;
however, a rearrangement of the c-myc oncogene is
detected as the dominant molecular change (21).
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Identification of oncogenes
could be as high as 25%. More than 80% of the trans-
forming genes detected in gene transfer assays have
been found to be members ofthe ras gene family.
Other human oncogenes identified by different ex-
perimental approaches were also found torepresent cel-
lular homologues of well-characterized retroviral on-
cogenes. For instance, the oncogene involved in the
chromosomal translocations characteristic of Burkitt's
lymphoma, c-myc, was first identified as the oncogene
of avian myelocytomatosis virus. Similarly, the onco-
gene implicated in the development of chronic myelo-
genous leukemia, c-abl, turned out to be the cellular
homologue of v-abl, the oncogene of Abelson murine
leukemia virus. These findings clearly illustrate the ex-
istence in human tumors of dominant oncogenes, some
of which correspond to those previously characterized
as responsible forthe carcinogenic effect ofacute trans-
forming retroviruses.
Cooperation of Cellular Oncogenes
The multistage nature ofcarcinogenesis has alsobeen
demonstrated with cellular oncogenes. The first pair of
cellular oncogenes found to cooperate were H-ras and
myc (24). Figure 6 illustrates these very important ex-
periments. The experiments showedthatiftheras gene
or the myc gene was transfected into primary cultures
ofembryo cells, no transformed foci were produced. On
Cotransfection Studies
Primary rat embryo
Rasgene fibroblasts
~~~~+
. F
no focus
FIGURE 5. Schematic diagram of a typical DNA transfection pro-
tocol where oncogenes can be isolated from cells transformed in
vitro by either radiation or chemical carcinogens. DNA sequences
are then characterized by genetic hybridization.
Oncogenes in Human Cancer
To date, about 24 oncogenes have been identified in
humancancerwiththetransfectionassay. Amongthem,
the most frequently found are members ofthe ras gene
family: H-ras, K-ras, and N-ras. H-ras and K-ras are
the cellular homologues ofthe oncogenes present in the
Harvey and Kirsten strains ofmurine sarcoma viruses.
The N-ras locus has so far not been transduced by re-
troviruses. Cellularrasgenesencodethep21 rasprotein
(22). They acquire transforming properties by single
point mutations along their coding sequence. The most
frequent mutated sites involve the codons for amino
acids 12, 13, or 61 (23). Identified in almost every form
of human cancer, ras oncogenes have an overall inci-
dence of 10% to 15%. In some types of tumor this per-
centage is significantly lower (e.g., breast carcinomas),
whereas in others (e.g., acute myelocytic leukemia) it
Ras gene
+
Primary rat embryo
Myc gene fibroblasts
Primary rat embryo
Myc + Ras fibroblasts
O 0 -
nofocus
FIGURE 6. Schematic illustration of the co-transfection studies of
Land et al. (24), in which a cooperation of both the ras and myc
genes are required to transform primary, nonimmortalized cells.
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the other hand, ifthe ras gene was transfected into the
already immortalized NIH 3T3 cells, foci were then ob-
served. To obtain transformed foci in fresh explants of
embryo 2ells it was necessary to transfect both the myc
and the ras oncogenes. It is generally considered that
the myc gene confers immortality, and the ras gene
produces the morphological changes characteristic of
transformation. Other examples of cooperating onco-
genes may involve oncogenes that have nuclear gene
products such as myc and p53 with genes that have
cytoplasmic gene products such as the ras and src.
More recent studies have suggested that the H-ras
gene site may be the direct target of chemical carcin-
ogens, and the H-ras oncogenes are activated during
the initiation phase of carcinogenesis. The implications
that the myc gene can suppress cellular differentiation
in progenitor cells in experimental tumor models and is
overexpressed in proliferating cells provide afunctional
explanation for the ras-myc cotransfection scheme. In
the case of radiation-induced transformation, experi-
ments parallel to those of Weinberg have been per-
formed (20): DNA from X-ray-transformed C3H 10T1/2
cells were transfected into three different recipient
cells, two ofthem established cell lines (1OT'/2 and 3T3)
and one of them a short embryo culture (hamster em-
bryo cells). The result ofthe experiments indicated that
focicouldonlybeproducedwhentherecipientcellswere
alreadyimmortalized, thatiswiththe3T3or10T1/2cells,
but no transformed clones were observed when the on-
cogenic DNA from the 10T1/2 cells was transfected into
the short-term cultures ofhamster embryo cells. These
radiation experiments again suggest that only one on-
cogene is necessary when the recipient cell line is al-
readyimmortalized, butthatmorethanoneisnecessary
toproduce transformation inprimarycelllines. The fact
that focus formation can be induced in ras-transfected
primary fibroblasts after application of the tumor pro-
motorTPA(25)andthatTPAcanenhancec-ras-induced
transformation in C3H 10T1/2 cells (26) suggestthatpro-
tein kinase C may be a common pathway for the induc-
tion of c-myc expression by both TPA and platelet-de-
rived growth factors.
Molecular Mechanisms of Radiation-
Induced Transformation
Ingeneral, oncogenescanbeactivatedbyoneofthree
processes; point mutation, a chromosome translocation
that moves the gene from an inactive to an active site,
and overexpression. Ionizing radiations are inefficient
in producing point mutations, but extremely effective
in inducing chromosomal translocations. Nothing is
known ofthe mechanisms wherebyradiationmayresult
ingeneamplification. Ofthethreeprincipalmechanisms
foroncogeneactivation, therefore, achromosometrans-
location would be the most likely to be induced by ra-
diation.
While the activation of a dominant oncogene is as-
sociated with some human malignancies, particularly
the leukemias and lymphomas, it appears that an in-
creasing number ofsolid tumors, such as small cell lung
carcinoma, colon cancer, and glioblastoma, result di-
rectly or indirectly from the loss ofa suppressor gene,
or what some have termed an anti-oncogene. Ionizing
radiations efficiently induce chromosome deletions, and
it may well be that radiation carcinogenesis in some
instances may be a consequence of the loss of a sup-
pressor gene.
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